Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProSeRePEA: PEAPROSTIL 600 and Tamsulosin for BPH
NCT06181175Recruiting
- Sponsor
- Azienda Ospedaliero-Universitaria Maggiore della Carità
- Start
- Oct 2021
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Randomised, open-label trial (3 arms), sponsored by Azienda Ospedaliero-Universitaria Maggiore della Carità. Primary endpoints: International Prostate Symptoms Score at 1 year and Quality of Life at 1 year. Started Oct 2021; status: recruiting.
Beyond the preview
Go deeper on NCT06181175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06181175.